vs
弗雷斯特研究公司（FORR）与ORTHOPEDIATRICS CORP（KIDS）财务数据对比。点击上方公司名可切换其他公司
弗雷斯特研究公司的季度营收约是ORTHOPEDIATRICS CORP的1.6倍（$101.1M vs $61.6M），ORTHOPEDIATRICS CORP净利率更高（-16.4% vs -33.5%，领先17.1%），ORTHOPEDIATRICS CORP同比增速更快（17.0% vs -6.5%），ORTHOPEDIATRICS CORP自由现金流更多（$9.7M vs $-4.3M），过去两年ORTHOPEDIATRICS CORP的营收复合增速更高（17.4% vs 0.5%）
福雷斯特研究公司是一家全球领先的研究咨询机构，主营业务涵盖行业研究、管理咨询与行业峰会举办，客户群体包括全球大型企业、科技公司与消费领域领军企业，公司总部位于美国马萨诸塞州剑桥市。
OrthoPediatrics是一家美国生物科技企业，总部位于印第安纳州华沙，专注于设计、研发、生产并分销用于儿科诊疗的骨科植入物与手术器械。
FORR vs KIDS — 直观对比
营收规模更大
FORR
是对方的1.6倍
$61.6M
营收增速更快
KIDS
高出23.4%
-6.5%
净利率更高
KIDS
高出17.1%
-33.5%
自由现金流更多
KIDS
多$14.0M
$-4.3M
两年增速更快
KIDS
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $101.1M | $61.6M |
| 净利润 | $-33.9M | $-10.1M |
| 毛利率 | 56.7% | 73.2% |
| 营业利润率 | -36.6% | -13.3% |
| 净利率 | -33.5% | -16.4% |
| 营收同比 | -6.5% | 17.0% |
| 净利润同比 | -7941.4% | 37.1% |
| 每股收益（稀释后） | $-1.75 | $-0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORRKIDS
| Q4 25 | $101.1M | $61.6M | ||
| Q3 25 | $94.3M | $61.3M | ||
| Q2 25 | $111.7M | $61.1M | ||
| Q1 25 | $89.9M | $52.4M | ||
| Q4 24 | $108.0M | $52.7M | ||
| Q3 24 | $102.5M | $54.6M | ||
| Q2 24 | $121.8M | $52.8M | ||
| Q1 24 | $100.1M | $44.7M |
净利润FORRKIDS
| Q4 25 | $-33.9M | $-10.1M | ||
| Q3 25 | $-2.1M | $-11.8M | ||
| Q2 25 | $3.9M | $-7.1M | ||
| Q1 25 | $-87.3M | $-10.7M | ||
| Q4 24 | $432.0K | $-16.1M | ||
| Q3 24 | $-5.8M | $-7.9M | ||
| Q2 24 | $6.3M | $-6.0M | ||
| Q1 24 | $-6.7M | $-7.8M |
毛利率FORRKIDS
| Q4 25 | 56.7% | 73.2% | ||
| Q3 25 | 60.0% | 73.9% | ||
| Q2 25 | 55.5% | 72.1% | ||
| Q1 25 | 55.9% | 73.0% | ||
| Q4 24 | 58.8% | 67.5% | ||
| Q3 24 | 60.5% | 73.4% | ||
| Q2 24 | 57.3% | 77.3% | ||
| Q1 24 | 54.9% | 72.0% |
营业利润率FORRKIDS
| Q4 25 | -36.6% | -13.3% | ||
| Q3 25 | 4.7% | -15.4% | ||
| Q2 25 | 6.2% | -17.4% | ||
| Q1 25 | -97.5% | -21.0% | ||
| Q4 24 | -0.5% | -26.7% | ||
| Q3 24 | -0.7% | -10.2% | ||
| Q2 24 | 9.3% | -10.7% | ||
| Q1 24 | -9.3% | -21.8% |
净利率FORRKIDS
| Q4 25 | -33.5% | -16.4% | ||
| Q3 25 | -2.3% | -19.2% | ||
| Q2 25 | 3.5% | -11.6% | ||
| Q1 25 | -97.1% | -20.3% | ||
| Q4 24 | 0.4% | -30.5% | ||
| Q3 24 | -5.7% | -14.5% | ||
| Q2 24 | 5.2% | -11.4% | ||
| Q1 24 | -6.7% | -17.5% |
每股收益（稀释后）FORRKIDS
| Q4 25 | $-1.75 | $-0.43 | ||
| Q3 25 | $-0.11 | $-0.50 | ||
| Q2 25 | $0.20 | $-0.30 | ||
| Q1 25 | $-4.62 | $-0.46 | ||
| Q4 24 | $0.02 | $-0.70 | ||
| Q3 24 | $-0.30 | $-0.34 | ||
| Q2 24 | $0.33 | $-0.26 | ||
| Q1 24 | $-0.35 | $-0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.3M | $60.9M |
| 总债务越低越好 | — | $106.0M |
| 股东权益账面价值 | $126.5M | $346.6M |
| 总资产 | $404.0M | $508.6M |
| 负债/权益比越低杠杆越低 | — | 0.31× |
8季度趋势，按日历期对齐
现金及短期投资FORRKIDS
| Q4 25 | $63.3M | $60.9M | ||
| Q3 25 | $65.1M | $57.7M | ||
| Q2 25 | $67.8M | $70.1M | ||
| Q1 25 | $75.6M | $58.8M | ||
| Q4 24 | $56.1M | $68.8M | ||
| Q3 24 | $62.8M | $76.1M | ||
| Q2 24 | $58.9M | $28.9M | ||
| Q1 24 | $61.4M | $47.7M |
总债务FORRKIDS
| Q4 25 | — | $106.0M | ||
| Q3 25 | — | $105.3M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M | ||
| Q1 24 | — | $11.3M |
股东权益FORRKIDS
| Q4 25 | $126.5M | $346.6M | ||
| Q3 25 | $157.7M | $349.3M | ||
| Q2 25 | $159.5M | $355.5M | ||
| Q1 25 | $147.4M | $347.1M | ||
| Q4 24 | $229.5M | $354.6M | ||
| Q3 24 | $234.3M | $370.9M | ||
| Q2 24 | $237.1M | $371.3M | ||
| Q1 24 | $230.9M | $370.6M |
总资产FORRKIDS
| Q4 25 | $404.0M | $508.6M | ||
| Q3 25 | $414.2M | $493.5M | ||
| Q2 25 | $436.0M | $503.6M | ||
| Q1 25 | $439.8M | $470.3M | ||
| Q4 24 | $503.9M | $473.2M | ||
| Q3 24 | $505.3M | $489.3M | ||
| Q2 24 | $524.2M | $430.8M | ||
| Q1 24 | $555.7M | $437.2M |
负债/权益比FORRKIDS
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× | ||
| Q1 24 | — | 0.03× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.2M | $10.3M |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | $9.7M |
| 自由现金流率自由现金流/营收 | -4.2% | 15.8% |
| 资本支出强度资本支出/营收 | 1.1% | 1.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $18.1M | $-16.0M |
8季度趋势，按日历期对齐
经营现金流FORRKIDS
| Q4 25 | $-3.2M | $10.3M | ||
| Q3 25 | $1.2M | $-581.0K | ||
| Q2 25 | $-3.6M | $-10.5M | ||
| Q1 25 | $26.7M | $-4.2M | ||
| Q4 24 | $-1.8M | $-4.0M | ||
| Q3 24 | $264.0K | $-10.3M | ||
| Q2 24 | $-2.9M | $-6.1M | ||
| Q1 24 | $611.0K | $-6.7M |
自由现金流FORRKIDS
| Q4 25 | $-4.3M | $9.7M | ||
| Q3 25 | $524.0K | $-3.4M | ||
| Q2 25 | $-4.2M | $-13.9M | ||
| Q1 25 | $26.1M | $-8.4M | ||
| Q4 24 | $-2.5M | $-4.2M | ||
| Q3 24 | $-223.0K | $-11.7M | ||
| Q2 24 | $-3.7M | $-12.8M | ||
| Q1 24 | $-815.0K | $-13.2M |
自由现金流率FORRKIDS
| Q4 25 | -4.2% | 15.8% | ||
| Q3 25 | 0.6% | -5.6% | ||
| Q2 25 | -3.8% | -22.8% | ||
| Q1 25 | 29.0% | -16.0% | ||
| Q4 24 | -2.3% | -8.1% | ||
| Q3 24 | -0.2% | -21.4% | ||
| Q2 24 | -3.1% | -24.2% | ||
| Q1 24 | -0.8% | -29.4% |
资本支出强度FORRKIDS
| Q4 25 | 1.1% | 1.0% | ||
| Q3 25 | 0.7% | 4.6% | ||
| Q2 25 | 0.5% | 5.6% | ||
| Q1 25 | 0.7% | 8.1% | ||
| Q4 24 | 0.6% | 0.5% | ||
| Q3 24 | 0.5% | 2.5% | ||
| Q2 24 | 0.7% | 12.7% | ||
| Q1 24 | 1.4% | 14.5% |
现金转化率FORRKIDS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.93× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -4.24× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.46× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FORR
| Research Segment | $82.2M | 81% |
| Consulting Segment | $16.2M | 16% |
| Billable Expenses | $1.5M | 2% |
| Professional Services | $1.4M | 1% |
KIDS
暂无分部数据
